Beyond The Roundup | Fact Checking The Fact Checkers: Associated Press VS Ivermectin
Fact Checking the Fact Checkers: The Case of Ivermectin for Publicly-Subsidized Research:On December 11, TrialSite News reported on a US […]
COVID-19 Early Treatment Fund & WUSM St. Louis Pursue Fluvoxamine as Early Stage Treatment for COVID-19: Positive Momentum
Washington University School of Medicine in St. Louis (WUSM St. Louis) investigators are now preparing for a critically important Phase 3 clinical […]
Moderna Receives FDA Advisory Committee Vote Supporting Emergency Use for Moderna’s Vaccine Against COVID-19 in the United States
Moderna, Inc., (Nasdaq:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative […]
U of M Medical School Research Led to FDA Approval of New Anti-obesity Medication for Adolescents
One in five teenagers in the U.S. is afflicted with obesity and the prevalence continues to rise. That statistic could […]
FDA Committee Votes to Recommend Emergency Use Authorization of Pfizer/BioNTech Coronavirus Vaccine
Reported by Maggie Fox with CNN, the US Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee voted […]
Moderna files for Emergency Use Authorization with FDA for mRNA-1273
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative […]
U.S. FDA Authorizes Regeneron’s REGN-COV2 Monoclonal Antibody for Emergency Use Authorization Targeting Select COVID-19 Patients
The monoclonal antibody cocktail developed by Regeneron and made well-known by POTUS during his stay at Walter Reed Medical Center […]
PFIZER AND BIONTECH TO SUBMIT EMERGENCY USE AUTHORIZATION REQUEST TODAY TO THE U.S. FDA FOR COVID-19 VACCINE
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced they will submit a request today to the U.S. Food and Drug Administration […]
Lilly’s Bamlanivimab (LY-CoV555) Receives FDA Emergency Use Authorization: A First COVID-19 Patients at High Risk
The U.S. Food and Drug Administration (FDA) today granted the first Emergency Use Authorization (EUA) for a monoclonal antibody targeting SARS-CoV-2, the […]
U.S. FDA Shares Final Guidance to Enhance Diversity of Clinical Trials
The COVID-19 pandemic has reminded all that track health, research and the impact of disease on minority and underserved or […]
